Literature DB >> 33750787

Implication of TIGIT+ human memory B cells in immune regulation.

Md Mahmudul Hasan1, Sumi Sukumaran Nair2, Jacqueline G O'Leary3, LuAnn Thompson-Snipes3, Verah Nyarige4, Junwen Wang4, Walter Park5, Mark Stegall5, Raymond Heilman2, Goran B Klintmalm3, HyeMee Joo6, SangKon Oh7.   

Abstract

Regulatory B cells (Bregs) contribute to immune regulation. However, the mechanisms of action of Bregs remain elusive. Here, we report that T cell immunoreceptor with Ig and ITIM domains (TIGIT) expressed on human memory B cells especially CD19+CD24hiCD27+CD39hiIgD-IgM+CD1c+ B cells is essential for effective immune regulation. Mechanistically, TIGIT on memory B cells controls immune response by directly acting on T cells and by arresting proinflammatory function of dendritic cells, resulting in the suppression of Th1, Th2, Th17, and CXCR5+ICOS+ T cell response while promoting immune regulatory function of T cells. TIGIT+ memory B cells are also superior to other B cells at expressing additional inhibitory molecules, including IL-10, TGFβ1, granzyme B, PD-L1, CD39/CD73, and TIM-1. Lack or decrease of TIGIT+ memory B cells is associated with increased donor-specific antibody and TFH response, and decreased Treg response in renal and liver allograft patients. Therefore, TIGIT+ human memory B cells play critical roles in immune regulation.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33750787      PMCID: PMC7943800          DOI: 10.1038/s41467-021-21413-y

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  65 in total

1.  Expression of alpha4beta7 and E-selectin ligand by circulating memory B cells: implications for targeted trafficking to mucosal and systemic sites.

Authors:  L S Rott; M J Briskin; E C Butcher
Journal:  J Leukoc Biol       Date:  2000-12       Impact factor: 4.962

Review 2.  Decisions about dendritic cells: past, present, and future.

Authors:  Ralph M Steinman
Journal:  Annu Rev Immunol       Date:  2011-11-17       Impact factor: 28.527

3.  HISAT: a fast spliced aligner with low memory requirements.

Authors:  Daehwan Kim; Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2015-03-09       Impact factor: 28.547

4.  Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.

Authors:  Aharon Kessel; Tharwat Haj; Regina Peri; Ayelet Snir; Doron Melamed; Edmond Sabo; Elias Toubi
Journal:  Autoimmun Rev       Date:  2011-12-02       Impact factor: 9.754

5.  Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut.

Authors:  A Kantele; J M Kantele; E Savilahti; M Westerholm; H Arvilommi; A Lazarovits; E C Butcher; P H Mäkelä
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

Review 6.  Antibody-mediated rejection in liver transplantation: current controversies and future directions.

Authors:  Timucin Taner; Mark D Stegall; Julie K Heimbach
Journal:  Liver Transpl       Date:  2014-02-25       Impact factor: 5.799

7.  CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.

Authors:  Li-Song Shen; Jian Wang; Ding-Feng Shen; Xiang-Liang Yuan; Ping Dong; Mei-Xing Li; Jian Xue; Feng-Min Zhang; Hai-Liang Ge; Dakang Xu
Journal:  Clin Immunol       Date:  2009-01-18       Impact factor: 3.969

8.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

9.  CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP.

Authors:  Chizuru Akatsu; Kenro Shinagawa; Nobutaka Numoto; Zhihong Liu; Ayse Konuskan Ucar; Mohammad Aslam; Shirly Phoon; Takahiro Adachi; Koji Furukawa; Nobutoshi Ito; Takeshi Tsubata
Journal:  J Exp Med       Date:  2016-10-24       Impact factor: 14.307

Review 10.  B cell regulation in cancer and anti-tumor immunity.

Authors:  Anushruti Sarvaria; J Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2017-06-19       Impact factor: 11.530

View more
  12 in total

Review 1.  Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation.

Authors:  Aravind Cherukuri; David M Rothstein
Journal:  Curr Opin Organ Transplant       Date:  2022-08-09       Impact factor: 2.269

Review 2.  TIGIT as a Promising Therapeutic Target in Autoimmune Diseases.

Authors:  Chenran Yue; Sheng Gao; Shuting Li; Zhouhang Xing; Hengrong Qian; Ying Hu; Wenqian Wang; Chunyan Hua
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

3.  Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis.

Authors:  S Shankar; J Stolp; S C Juvet; J Beckett; P S Macklin; F Issa; J Hester; K J Wood
Journal:  Nat Commun       Date:  2022-06-03       Impact factor: 17.694

Review 4.  Regulation of Alloantibody Responses.

Authors:  Anita S Chong; Peter T Sage; Maria-Luisa Alegre
Journal:  Front Cell Dev Biol       Date:  2021-07-08

5.  TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4+ T cells.

Authors:  Kayla A Holder; Kimberley Burt; Michael D Grant
Journal:  Clin Transl Immunology       Date:  2021-10-19

6.  Identification of Potential Immune Checkpoint Inhibitor Targets in Gliomas via Bioinformatic Analyses.

Authors:  Mengmeng Ding; Yong-An Li; Zhimin Lu; Guoxin Hou
Journal:  Biomed Res Int       Date:  2022-02-14       Impact factor: 3.411

7.  Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets.

Authors:  Marla C Glass; David R Glass; John-Paul Oliveria; Berenice Mbiribindi; Carlos O Esquivel; Sheri M Krams; Sean C Bendall; Olivia M Martinez
Journal:  Cell Rep       Date:  2022-04-19       Impact factor: 9.995

Review 8.  Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy.

Authors:  Daijun Wang; Yanmei Gu; Xin Yan; Chengdong Huo; Guan Wang; Yang Zhao; Muzhou Teng; Yumin Li
Journal:  Front Oncol       Date:  2022-03-30       Impact factor: 6.244

9.  Deconvolution of B cell receptor repertoire in multiple sclerosis patients revealed a delay in tBreg maturation.

Authors:  Yakov A Lomakin; Ivan V Zvyagin; Leyla A Ovchinnikova; Marsel R Kabilov; Dmitriy B Staroverov; Artem Mikelov; Alexey E Tupikin; Maria Y Zakharova; Nadezda A Bykova; Vera S Mukhina; Alexander V Favorov; Maria Ivanova; Taras Simaniv; Yury P Rubtsov; Dmitriy M Chudakov; Maria N Zakharova; Sergey N Illarioshkin; Alexey A Belogurov; Alexander G Gabibov
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

Review 10.  Regulatory B Cell Therapy in Kidney Transplantation.

Authors:  Sergio G Garcia; Noelia Sandoval-Hellín; Marcella Franquesa
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.